title: Topical cream delivers NB-UVB from sunlight for the treatment of vitiligo.
abstract: Ultraviolet-B (UVB) phototherapy for the treatment of vitiligo is an effective first-line choice. However, the cost of multiple doctor visits and the lengthy treatment regimen has resulted in low compliance, limiting access to this safe and effective mode of treatment. Topical Photocil represents an innovative solution to this problem. The drug selectively filters solar radiation to deliver narrow-band UVB to vitiligo lesions. Here, we discuss how this novel topical cream could provide a convenient alternative to artificial light phototherapy.
authors.affiliation: Applied Biology , 17780 Fitch, Suite 192, Irvine, CA 92614 , USA johnm@appliedbiology.com.
authors.forename: Xingang
authors.initials: X
authors.lastname: Wang
authors.forename: John
authors.initials: J
authors.lastname: McCoy
authors.forename: Torello
authors.initials: T
authors.lastname: Lotti
authors.forename: Andy
authors.initials: A
authors.lastname: Goren
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D065095:Calcineurin Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D010789:Phototherapy; D011859:Radiography; D014467:Ultraviolet Therapy; D014807:Vitamin D / Q000031:analogs & derivatives / Q000627:therapeutic use; D014820:Vitiligo / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000601:surgery
chemical_list: D000305:Adrenal Cortex Hormones; D065095:Calcineurin Inhibitors; D014807:Vitamin D
keywords: Photocil; phototherapy; topical; vitiligo